This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Osaka, K. Articles by Kagan, V. E. Search for Related Content PubMed PubMed Citation Articles by Osaka, K. Articles by Kagan, V. E.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, Apr 1997, 743-747, Vol 41, No. 4
Copyright © 1997 by the American Society for Microbiology. All rights reserved.

Amphotericin B protects cis-parinaric acid against peroxyl radical- induced oxidation: amphotericin B as an antioxidant

K Osaka, VB Ritov, JF Bernardo, RA Branch and VE Kagan
Department of Environmental and Occupational Health, University of Pittsburgh, Pennsylvania 15238, USA.

The antifungal effects of amphotericin B are believed to be due to two possibly interrelated mechanisms: an increase in permeation by binding to sterols in cellular membranes and a prooxidant effect causing oxidative damage in target cells. However, the seven conjugated double bonds in amphotericin B raise the possibility that it could be highly susceptible to autoxidation, causing an antioxidant effect. In the present study, we investigated the prooxidant and antioxidant properties of amphotericin B in a model system in which oxidation of a reporter molecule, cis-parinaric acid, was induced by azo initiators of peroxyl radicals. Since interactions of amphotericin B with sterols are essential for its pharmacological and toxic actions, we also studied the effects of cholesterol on the prooxidant and antioxidant properties of amphotericin B. Amphotericin B caused a noncollisional quenching of a characteristic fluorescence of cholesteryl cis-parinarate integrated in liposomes, suggesting the formation of amphotericin B-cholesteryl cis-parinarate complex. This effect of amphotericin B was ablated by increasing concentrations of cholesterol. We found that amphotericin B inhibited oxidation of cis-parinaric acid complexed with human serum albumin [using a water-soluble azo initiator, 2,2'- azobis(2aminopropane)dihydrochloride] and in liposomes [using a lipid- soluble azo initiator, 2,2'-azobis(2,4-dimethylvaleronitrile)]. The inhibitory effect of amphotericin B on 2,2'-azobis(2,4- dimethylvaleronitrile)-induced peroxidation of cis-parinaric acid in liposomes was also diminished by cholesterol. The antioxidant effect of amphotericin B in this model system suggests that amphotericin B does not exert its pharmacological and toxicological responses through a prooxidant effect to cause damage in target cells.

This article has been cited by other articles:

• Kuipers, M. E., de Vries, H. G., Eikelboom, M. C., Meijer, D. K. F., Swart, P. J. (1999). Synergistic Fungistatic Effects of Lactoferrin in Combination with Antifungal Drugs against Clinical Candida Isolates. Antimicrob. Agents Chemother. 43: 2635-2641 [Abstract] [Full Text]  
• White, T. C., Marr, K. A., Bowden, R. A. (1998). Clinical, Cellular, and Molecular Factors That Contribute to Antifungal Drug Resistance. Clin. Microbiol. Rev. 11: 382-402 [Abstract] [Full Text]